Edition:
United States

Cocrystal Pharma Inc (COCP.OQ)

COCP.OQ on NASDAQ Stock Exchange Capital Market

2.70USD
12 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,634
52-wk High
$6.43
52-wk Low
$1.61

Chart for

About

Cocrystal Pharma, Inc., is a clinical stage biotechnology company. The Company focuses on discovering and developing novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company focuses on developing and commercializing antiviral drug candidates for the treatment and prophylaxis of hepatitis... (more)

Overall

Beta: 1.93
Market Cap(Mil.): $178.00
Shares Outstanding(Mil.): 726.53
Dividend: --
Yield (%): --

Financials

  COCP.OQ Industry Sector
P/E (TTM): -- 30.89 32.75
EPS (TTM): -0.10 -- --
ROI: -41.96 15.08 14.60
ROE: -52.95 16.60 16.33

BRIEF-Cocrystal Pharma Posts Qtrly Net Loss Of About $1.6 Mln

* COCRYSTAL PHARMA REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 11 2018

BRIEF-Cocrystal Pharma Prices $8,000,000 Common Stock Offering

* COCRYSTAL PHARMA, INC., PRICES $8,000,000 COMMON STOCK OFFERING

May 01 2018

Earnings vs. Estimates